Gene · 9055
Papers4,169
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,169
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers. | Biomed Res Int | 2023 | 38046902 | PubTator, text mining | PubMed |
| Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells. | Heliyon | 2023 | 38046164 | PubTator, text mining | PubMed |
| Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy. | Redox Biol | 2023 | 38035663 | PubTator, text mining | PubMed |
| Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers. | Front Mol Biosci | 2023 | 38028548 | PubTator, text mining | PubMed |
| Clinical Investigation of Hereditary and Acquired Thrombophilic Factors in Patients with Venous and Arterial Thromboembolism. | Int J Gen Med | 2023 | 38021042 | PubTator, text mining | PubMed |
| GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization. | Oncol Lett | 2023 | 38020290 | PubTator, text mining | PubMed |
| Cis- and trans-eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia. | bioRxiv | 2023 | 38014246 | PubTator, text mining | PubMed |
| Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. | Genome Biol | 2023 | 38012744 | PubTator, text mining | PubMed |
| Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation. | mBio | 2023 | 38009935 | PubTator, text mining | PubMed |
| LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex. | Cell Death Dis | 2023 | 38007473 | PubTator, text mining | PubMed |
| Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease. | Int J Mol Sci | 2023 | 38003316 | PubTator, text mining | PubMed |
| Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma. | Sci Adv | 2023 | 37992172 | PubTator, text mining | PubMed |
| IndiSPENsable for X Chromosome Inactivation and Gene Silencing. | Epigenomes | 2023 | 37987303 | PubTator, text mining | PubMed |
| Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts. | Aging (Albany NY) | 2023 | 37980163 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development. | World J Gastrointest Oncol | 2023 | 37969406 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition: an organizing principle of mammalian regeneration. | Front Cell Dev Biol | 2023 | 37965571 | PubTator, text mining | PubMed |
| Modularity of PRC1 Composition and Chromatin Interaction define Condensate Properties. | bioRxiv | 2023 | 37961190 | PubTator, text mining | PubMed |
| Combined Multiplexed Phage Display, High-Throughput Sequencing, and Functional Assays as a Platform for Identifying Modulatory VHHs Targeting the FSHR. | Int J Mol Sci | 2023 | 37958944 | PubTator, text mining | PubMed |
| Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents. | J Enzyme Inhib Med Chem | 2023 | 37955299 | PubTator, text mining | PubMed |
| miR‑149‑3p suppresses the proliferation and metastasis of glioma cells by targeting the CBX2/Wnt/β‑catenin pathway. | Exp Ther Med | 2023 | 37954123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9055/papers?page=14